您的购物车当前为空
SRI-37330 抑制胰高血糖素的分泌和功能,减少肝葡萄糖的产生,并逆转肝脂肪变性。

SRI-37330 抑制胰高血糖素的分泌和功能,减少肝葡萄糖的产生,并逆转肝脂肪变性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 478 | In stock | |
| 5 mg | ¥ 996 | In stock | |
| 10 mg | ¥ 1,790 | In stock | |
| 25 mg | ¥ 3,950 | In stock | |
| 50 mg | ¥ 5,630 | In stock | |
| 100 mg | ¥ 7,880 | In stock | |
| 200 mg | ¥ 10,600 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 956 | In stock |
| 产品描述 | SRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production, and reverses hepatic steatosis. |
| 分子量 | 388.41 |
| 分子式 | C16H19F3N4O2S |
| CAS No. | 2322245-42-9 |
| Smiles | CS(=O)(=O)NCC1CCCN(C1)c1ncnc2ccc(cc12)C(F)(F)F |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 45 mg/mL (115.86 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (12.87 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容